MedPath
HSA Approval

VELBASTINE FOR INJECTION 10 mg/vial

SIN10987P

VELBASTINE FOR INJECTION 10 mg/vial

VELBASTINE FOR INJECTION 10 mg/vial

June 24, 1999

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

L01CA01

vinblastine

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARMACEUTICAL INC

Active Ingredients

VINBLASTINE SULPHATE

10 mg/vial

Vinblastine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VELBASTINE FOR INJECTION 10 mg/vial - HSA Approval | MedPath